Almac Diagnostic Services’ claraT Report Assists Researchers In Uncovering New Oncology Findings
Dec.8, 2021 | In Dr Analiz Rodriguez’s study, claraT was utilized as a method to facilitate the molecular profiling of brain metastases. Together with other genomic and transcriptomic tools, claraT helped identify novel molecular subtypes and new drivers of brain cancer progression in parallel to novel drug targets. These findings have been published in the MDPI Cancer Journal.
Dr. Rodriguez said “We are grateful for the Almac Group’s claraT platform as it allowed us to evaluate hundreds of gene expression signatures and single gene targets that correlated to the Hallmarks of Cancer. Transcriptome data can be difficult to analyze, especially in our heterogenous dataset which included brain metastases samples from various primary cancer subtypes. The claraT software solution immensely simplified our workflow and helped us identify a novel subgroup of brain metastases which warrants further investigation.” See full article.
UAMS’ Analiz Rodriguez, M.D., Ph.D., Selected for Diversity in Clinical Trials Career Development Program
Nov. 23, 2021 | The Bristol Myers Squibb Foundation (BMSF), along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences (UAMS) neurosurgeon Analiz Rodriguez, M.D., Ph.D., to participate in its Diversity in Clinical Trials Career Development Program. See full story.
Grant Gives UAMS Physician-Scientists Access to Gene Analysis Software
July 24, 2020 | Analiz Rodriguez, M.D, Ph.D., received a grant from Almac Diagnositics Services to further her study of brain metastases. See full story
UAMS Researchers Find insurance Status Affects Treatment, Outcomes in Child Brain Injuries
July 13, 2020 | Insurance status affected the amount of treatment received and the patient’s chance of survival in cases of brain injury in children, a team of researchers from the University of Arkansas for Medical Sciences (UAMS) found in a study that used nationwide data. See full story.
COM Accolades: Glioma Biomakers
July 1, 2020 | Congratulations to Dr. Analiz Rodriguez, Director of Neurosurgical Oncology in the Department of Neurosurgery, Dr. Thidathip Wongsurawat, Instructor in Biomedical Informatics, and colleagues on the publication of their collaborative study of a new sequencing technique to identify biomarkers in patient glioma samples. Dr. Wongsurawat was the first author and Dr. Rodriguez was the senior author on the paper published in Acta Neuropathologica Communications. Other authors included Dr. Piroon Jenjaroenpun, Dr. Intawat Nookaew and Dr. David Ussery in Biomedical Informatics; Biochemistry and Molecular Biology graduate student Duah Alkam; Annick De Loose and Dr. J.D. Day in Neurosurgery; and Pharmacology and Toxicology’s Dr. Ricky Leung and Dr. Shuk-Mei Ho. See full Accolades.
Darrigues selected for competitive postdoctoral research program at UAMS
May 18, 2020 | Emilie Darringues, a University of Arkansas at Little Rock doctoral student has been selected for a highly competitive postdoctoral scholarship at the University of Arkansas for Medical Sciences (UAMS). See full story.
UAMS Scientists Awarded Grants for Cancer Research
March 19, 2020 | Newly awarded grants are advancing research efforts at the UAMS Winthrop P. Rockefeller Cancer Institute. The 2020 Seeds of Science cancer research grant recipients are Michael Bauer, Ph.D.; Carolina Schinke, M.D.; Kimberly Stephens, Ph.D., M.P.H., R.N.; and Analiz Rodriguez, M.D., Ph.D. See full story.
COM Accolades: Neurosurgery Student Fellowship
May 9, 2019 | COM freshman Jeffrey “Curran” Henson is one of fewer than 30 medical students nationwide to receive a prestigious Neurosurgery Research and Education Foundation 2019 Medical Student Summer Research Fellowship. He will be mentored by Dr. Analiz Rodriguez, Assistant Professor of Neurosurgery and Director of Neurosurgical Oncology at UAMS. Congratulations Curran! See full Accolades.
Arkansas Business 40 Under 40 Class of 2019: Dr. Analiz Rodriguez
June 6, 2019 | Congratulations to Dr. Analiz Rodriguez of the Department of Neurosurgery, who was named to the Arkansas Business 40 Under 40. Dr. Rodriguez said she wants to give Arkansans “the opportunity to get the best care possible for their brain tumor, so they don’t have to leave the state. And then … we hope to potentially develop new therapies for them.” See full story.
UAMS Cancer Researchers Receive NIH Grant to Develop New Cancer Therapies
November 13, 2018 | The National Institutes of Health (NIH) awarded the three-year grant to Karen Abbott, Ph.D., assistant professor in the UAMS College of Medicine’s Department of Biochemistry and Molecular Biology, and Analiz Rodriguez, M.D., Ph.D., assistant professor in the UAMS College of Medicine’s Department of Neurosurgery. Abbott is principal investigator for the grant, and Rodriguez is co-investigator. See full story.
Dr. Analiz Rodriguez Awarded 2018 Seeds of Science Grant
January 29, 2018 | The newly awarded grant will assist scientists at the UAMS Winthrop P. Rockefeller Cancer Institute in their search for new and innovative cancer treatments. The grants of $10,000 each were presented to young investigators by the Envoys, a volunteer advocacy group of the Cancer Institute Foundation, during their “Doctor is In” reception and research poster showcase Jan. 25. See full story.